Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer—A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib
Titel:
Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer—A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib
Auteur:
Symonds, Lynn Linden, Hannah Gadi, Vijayakrishna Korde, Larissa Rodler, Eve Gralow, Julie Redman, Mary Baker, Kelsey Wu, Quan (Vicky) Jenkins, Isaac Kurland, Brenda Garrison, Mitchell Smith, Julie Anderson, Jeanne Van Haelst, Carol Specht, Jennifer